Temporal expression pattern of Duffy antigen in rheumatoid arthritis: Up-regulation in early disease

Arthritis and Rheumatism

Volumn 54, Issue 6, 2006, Pages 2022-2026

  Gardner, Lucy ^a   Wilson, Catherine ^a   Patterson, Angela M ^a   Bresnihan, Barry ^b   FitzGerald, Oliver ^b   Stone, Michael A ^c   Ashton, Brian A ^a   Middleton, Jim ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; BLOOD GROUP DUFFY ANTIGEN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DUFFY BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; ARTICULAR CARTILAGE; BIOPSY; BLOOD GROUP DUFFY SYSTEM; EARLY DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RHEUMATOID ARTHRITIS; TISSUE SECTION;

ARTHRITIS, RHEUMATOID; DUFFY BLOOD-GROUP SYSTEM; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; SYNOVIAL MEMBRANE; TIME FACTORS;

EID: 33745021093     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21909     Document Type: Article

References (23)

1. Kashiwazaki M, Tanaka T, Kanda H, Ebisuno Y, Izawa D, Fukuma N, et al. A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. Int Immunol 2003;15:1219-27.
2. Gardner L, Patterson AM, Ashton BA, Stone MA, Middleton J. The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. Biochem Biophys Res Commun 2004;321:306-12.
3. Nibbs R, Graham G, Rot A. Chemokines on the move: control by the chemokine "interceptors" Duffy blood group antigen and D6. Semin Immunol 2003;15:287-94.
4. Hadley TJ, Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997;89:3077-91.
5. Patterson AM, Chamberlain G, Siddall H, Gardner L, Middleton J. Expression of the Duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium. J Pathol 2002;197:108-16.
6. Middleton J, Americh L, Gayon R, Julien D, Mansat M, Mansat P, et al. A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, DARC (Duffy antigen receptor for chemokines), von Willebrand factor, CD31, CD34, CD105 and CD146. J Pathol 2005;206:260-8.
7. Lee JS, Frevert CW, Wurfel MM, Peiper SC, Wong VA, Ballman KK, et al. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol 2003;170:5244-51.
8. Rot A. Contribution of Duffy antigen to chemokine function. Cytokine Growth Factor Rev 2005;16:687-94.
9. Chaudhuri A, Nielsen S, Elkjaer M, Zbrzezna V, Fang F, Pogo AO. Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 1997;89:701-12.
10. Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C, et al. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997;91:385-95.
11. Dawson TC, Lentsch AB, Wang Z, Cowhig JE, Rot A, Maeda N, et al. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 2000;96:1681-4.
12. Luo H, Chaudhuri A, Zbrzezna V, He Y, Pogo AO. Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol Cell Biol 2000;20:3097-101.
13. Luo H, Chaudhuri A, Zbrzezna V, He Y, Pogo AO. Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol Cell Biol 2003;23:3030.
14. Arnett-FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Kirkham B, Portek I, Lee CS, Stavros B, Lenarczyk A, Lassere M, et al. Intraarticular variability of synovial membrane histology, immunohistology, and cytokine mRNA expression in patients with rheumatoid arthritis. J Rheumatol 1999;26:777-84.
16. Blanchard D, Tournamille C, Petit-Le Roux Y, Wasiowska K, LeVanKim C, Loirat MJ, et al. A new murine monoclonal antibody directed against FY6 antigen [abstract]. Vox Sang 1998;74 Suppl 1:71.
17. Liu X, Hadley TJ, Xu L, Peiper SC, Ray PE. Up-regulation of Duffy antigen receptor expression in children with renal disease. Kidney Int 1999;55:1491-500.
18. Segerer S, Regele H, Mack M, Kain R, Cartron JP, Colin Y, et al. The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int 2000;58:1546-56.
19. Lee JS, Frevert CW, Thorning DR, Segerer S, Alpers CE, Cartron JP, et al. Enhanced expression of Duffy antigen in the lungs during suppurative pneumonia. J Histochem Cytochem 2003;51:159-66.
20. Pablos JL, Santiago B, Galindo M, Torres C, Brehmer MT, Blanco FJ, et al. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 2003;170:2147-52.
21. Katrib A, Tak PP, Bertouch JV, Cuello C, McNeil HP, Smeets TJ, et al. Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis. Rheumatology (Oxford) 2001;40:988-94.
22. Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN, et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005;7:R784-95.
23. Szabo M, Soo KS, Zlotnik A, Schall TJ. Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J Biol Chem 1995;270:25348-51.